Found 6 matching trials
Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS) PHASE1 The goal of this study is to evaluate the safety and feasibility of IVIg ad...
Show More Status
Active Not Recruiting
Location
Sunnybrook Health Sciences Centre
Learn More & Join Trial
Assessment of Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Disorders of Consciousness NA The main questions this study aims to answer are:
Can low-intensity FUS ne...
Show More Location
Sunnybrook Health Sciences Centre
Learn More & Join Trial
Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Treatment Refractory Obsessive Compulsive Disorder (OCD) NA This study evaluates the safety, feasibility, and preliminary efficacy of f...
Show More Location
Sunnybrook Health Sciences Centre
Learn More & Join Trial
Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy PHASE1 The goal of this clinical trial is to evaluate the safety and feasibility o...
Show More Location
Sunnybrook Health Sciences Centre
Learn More & Join Trial
Safety and Feasibility of Next-Generation Dome Helmet (NGDH) for Focused Ultrasound Neuromodulation in Substance Use Disorder (SUD) NA The goal of this clinical trial is to evaluate the safety, feasibility, and...
Show More Location
Sunnybrook Health Sciences Centre
Learn More & Join Trial
Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression NA The goal of this clinical trial is to evaluate the safety and initial effec...
Show More Location
Sunnybrook Health Sciences Centre
Learn More & Join Trial